Shire closer to deal to buy Baxalta, report says

Baxalta's board rejected an all-share bid from Shire in August

23rd December, 2015
Irish-based Shire has been pursuing Baxalta for five months

Drug maker Shire has made a new acquisition offer for peer Baxalta International that is roughly in line with the latter's valuation expectations, making a deal in the coming weeks likely, people familiar with the matter said.

Reuters reported that an agreement would successfully end Dublin-based Shire's five-month pursuit of Illinois-based Baxalta and create one of the world's leading specialists in rare diseases.

Baxalta's board rejected an all-share offer from Shire in August, saying it...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Nadine O’Regan: Fishing for compliments at our own funerals

Emer McLysaght: Take it or leave it, Father’s Day is not an issue

Columnists Emer McLysaght 14 hours ago

Analysis: Moral hazard at the heart of public health leaders’ reluctance to begin use of rapid antigen testing

Coronavirus Daniel Murray 14 hours ago

Elaine Byrne: What structural defect means taxpayers always carry the can?

Politics Elaine Byrne 14 hours ago